Vortioxetine eases depression in older adults, while cognitive gains stay mixed—showing selective boosts in attention and processing speed, not consistent global improvement.
|Slideshows|August 10, 2017
New Portents of Alzheimer Disease
Author(s)Mark L. Fuerst
Researchers investigate Alzheimer disease in 3 key areas: sleep, seizures, and proton pump inhibitors.
Advertisement
View the slides in PDF format.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Improving but Not Feeling It: Anticipatory Anhedonia and Cognition
2
Comparison of Atypical Antipsychotics as Adjunctive Treatments for Major Depressive Disorder
3
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
4
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
5